Since October 7, 2023, our strongest ally in the Middle East, Israel, has withstood various terrorist attacks from Iran and its proxies, including Hamas, Palestinian Islamic Jihad, Hezbollah, and others. Instead of standing by Jerusalem, the Biden-Harris...
News
Latest News
Rubio: “The Court is Right: Algorithms Should Not Enjoy Section 230 Protections”
TikTok was recently sued after a 10-year-old girl died from taking part in a viral challenge that dared users on the app to choke themselves until they passed out. Courts have historically protected social media companies over user-generated content due to...
Rubio, Moolenaar Demand Communist China-linked Battery Company Be Blacklisted
Contemporary Amperex Technology Limited (CATL) is an electric vehicle battery company with deep ties to the Chinese Communist Party and its armed wing, the People’s Liberation Army (PLA). Reliance on, and use of, CATL batteries threatens U.S. national security as it...
Rubio: Communist China Making a Mockery of Biden-Harris Administration
Despite the serious threats the Chinese Communist Party poses to the United States and our allies, National Security Advisor Jake Sullivan is in the midst of a three day visit with Chinese Foreign Minister Wang Yi in another embarrassing attempt to “lower tensions”...
Rubio Calls on John Deere to Prioritize American Workers
John Deere, the world’s largest tractor manufacturer, is a staple of American business and a crucial supplier for the hard working Americans who grow our food. Recently, after receiving public backlash, John Deere ended several ridiculous Diversity, Equity, and...
Rubio Y Colegas: Esto No Se Trata de Ideología Política, Se Trata de Defender la Voluntad del Pueblo Venezolano
Hace casi un mes, el pueblo venezolano votó por Edmundo González Urrutia como su presidente electo. Ayer, el Tribunal Supremo de Justicia del narco-régimen de Maduro optó por legitimar el fraude electoral de la dictadura. Los senadores estadounidenses Marco Rubio...
Rubio, Rosen Reintroduce Bipartisan Legislation to Study the Full Health Impacts of Covid-19
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Jacky Rosen (D-NV) reintroduced the bipartisan Ensuring Understanding of COVID-19 to Protect Public Health Act, legislation that would direct the National Institutes of Health (NIH) to conduct a longitudinal study on mild, moderate, and severe cases of COVID-19 to ensure we gain a full understanding of both the short and long-term health impacts of the novel coronavirus. Rubio and Rosen first introduced the legislation in May 2020.
“As our nation continues to battle the coronavirus pandemic, it is critical that our health care experts at the NIH conduct a comprehensive study to help guide physicians caring for patients with COVID-19,” Rubio said. “There are still numerous unknowns about COVID-19, including its potential long-term health impacts, and this bipartisan bill provides the NIH with important guidelines to study this virus.”
“As our country continues to battle this virus, we must ensure we continue to examine all aspects of how COVID-19 affects patients from diverse populations,” Rosen said. “By focusing our nation’s efforts toward understanding the short and long-term health ramifications of COVID-19, we can arm our researchers and medical professionals with the most accurate data as they work to provide better treatment and vaccines for patients. I will continue working to protect the health of Nevadans during this unprecedented time.”
Background: More specifically, the bipartisan Ensuring Understanding of COVID-19 to Protect Public Health Act would direct the NIH to:
-
Conduct a nationwide study of the health outcomes and symptoms of COVID-19, including long-term impact on lung function and immune response, and the impact of treatments.
-
The study would include a wide variety of patients, to ensure diversity among race, ethnicity, geography, age, gender, and underlying health conditions; and
-
Monitor mental health outcomes.
-
The goal of the study is to gain a full understanding of both the short-term and long-term health impacts of COVID-19.
The findings would be released publicly every 3 months for the first two years, and every 6 months thereafter.